Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pfizer announces retirement of vice-chairman

Pfizer announces retirement of vice-chairman

29th October 2007

Pfizer has announced that David L Shedlarz, vice-chairman of the company since 2005, will retire from the firm at the end of 2007.

Since joining the firm in 1976, Mr Shedlarz has served in a number of roles of increasing responsibility, being appointed vice-president of finance at the company’s US Pharmaceuticals group in 1989 before being promoted to vice president of finance three years later.

He was elected as chief financial officer in 1995 and named senior vice-president with responsibility for the medical technology group in 1997 and executive vice-president in 1999.

During his tenure, Mr Shedlarz was vital to work undertaken to shape the strategic direction of the company, leading the integration of Pharmacia into the firm and playing a key role in the sale of the consumer healthcare division.

Jeffrey B Kindler, chairman and chief executive officer of Pfizer, said: “Throughout his Pfizer career, David Shedlarz has demonstrated integrity and an enduring commitment to our company and its mission.”

He added that Mr Shedlarz has been a worthy partner since his own appointment to the position of chief executive officer in 2006, with both collaborating as part of a team driving radical change in business operations at Pfizer.

Earlier this month, Pfizer released an independent report assessing the status of international corporate volunteering programmes in conjunction with the Brookings Institution’s Initiative on International Volunteering and Service and FSG Social Impact Advisers.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.